Global Asthma Drugs Market Drug Class (Combination therapies (ICS/LABAs), Long-acting beta agonists (LABAs), Short-acting beta agonists (SABAs), Inhaled corticosteroids (ICS), Oral and intravenous corticosteroids, Leukotriene modifiers, Other drug classes) Product ( Inhalers, Dry Powder, Metered Dose, Soft Mist, Nebulizers) Route of Administration (Oral, Inhaled, Others) By Distribution (Channel, Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, E-Commerce) By End-use, Hospitals & clinics, Ambulatory surgical centers, Homecare settings) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Oct 2024
- Report ID: 130279
- Number of Pages:
- Format:
- keyboard_arrow_up
Table of Contents
- 1. Executive Summary
- 1.1. Definition
- 1.2. Market Snapshot
- 1.3. Market Overview
- 1.4. Segment Overview
- 1.5. Regional Overview
- 1.6. Competitive Landscape
- 1.7. Taxonomy
- 2. Global Market Overview
- 2.1. Global Market Insights and Industry Overview
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunities
- 2.2.4. Key Asthma Drugs Market Trends
- 2.3. Regulatory Framework
- 2.4. Opportunity Map Analysis
- 2.5. Opportunity Orbits
- 2.6. PESTLE Analysis
- 2.7. PORTER’S Five Force Analysis
- 2.8. Drivers & Restraints Impact Analysis
- 2.9. Value Chain Analysis
- 2.9.1. List of Raw Materials Suppliers
- 2.9.2. List of Asthma Drugs Manufacturers
- 2.9.3. List of Dealer/Distributors
- 2.10. Regional Market Share and BPS Analysis
- 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Asthma Drugs Market Analysis and Forecast, By Segment, 2019-2033
- 3.1. Key Findings
- 3.2. Global Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 3.3. Global Asthma Drugs Market Attractiveness Analysis, By Drug Class
- 3.3.1. Combination therapies (ICS/LABAs)
- 3.3.1.1. Insights
- 3.3.1.2. Key Takeaways
- 3.3.2. Long-acting beta agonists (LABAs)
- 3.3.2.1. Insights
- 3.3.2.2. Key Takeaways
- 3.3.3. Short-acting beta agonists (SABAs)
- 3.3.3.1. Insights
- 3.3.3.2. Key Takeaways
- 3.3.4. Inhaled corticosteroids (ICS)
- 3.3.4.1. Insights
- 3.3.4.2. Key Takeaways
- 3.3.5. Oral and intravenous corticosteroids
- 3.3.5.1. Insights
- 3.3.5.2. Key Takeaways
- 3.3.6. Leukotriene modifiers
- 3.3.6.1. Insights
- 3.3.6.2. Key Takeaways
- 3.3.7. Other drug classes
- 3.3.7.1. Insights
- 3.3.7.2. Key Takeaways
- 3.3.1. Combination therapies (ICS/LABAs)
- 3.4. Global Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 3.5. Global Asthma Drugs Market Attractiveness Analysis, By Product
- 3.5.1. Inhalers
- 3.5.1.1. Insights
- 3.5.1.2. Key Takeaways
- 3.5.2. Nebulizers
- 3.5.2.1. Insights
- 3.5.2.2. Key Takeaways
- 3.5.1. Inhalers
- 3.6. Global Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 3.7. Global Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- 3.7.1. Oral
- 3.7.1.1. Insights
- 3.7.1.2. Key Takeaways
- 3.7.2. Inhaled
- 3.7.2.1. Insights
- 3.7.2.2. Key Takeaways
- 3.7.3. Others
- 3.7.3.1. Insights
- 3.7.3.2. Key Takeaways
- 3.7.1. Oral
- 3.8. Global Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 3.9. Global Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- 3.9.1. Online Pharmacies
- 3.9.1.1. Insights
- 3.9.1.2. Key Takeaways
- 3.9.2. Hospital Pharmacies
- 3.9.2.1. Insights
- 3.9.2.2. Key Takeaways
- 3.9.3. Retail Pharmacies
- 3.9.3.1. Insights
- 3.9.3.2. Key Takeaways
- 3.9.4. E-Commerce
- 3.9.4.1. Insights
- 3.9.4.2. Key Takeaways
- 3.9.1. Online Pharmacies
- 3.10. Global Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2019-2033
- 3.11. Global Asthma Drugs Market Attractiveness Analysis, By End-User
- 3.11.1. Hospitals & clinics
- 3.11.1.1. Insights
- 3.11.1.2. Key Takeaways
- 3.11.2. Ambulatory surgical centers
- 3.11.2.1. Insights
- 3.11.2.2. Key Takeaways
- 3.11.3. Homecare settings
- 3.11.3.1. Insights
- 3.11.3.2. Key Takeaways
- 3.11.1. Hospitals & clinics
- 4. Global Asthma Drugs Market Analysis and Forecast, By Region, 2019-2033
- 4.1. Key Findings
- 4.2. Global Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
- 4.2.1. North America
- 4.2.1.1. Regional Insights
- 4.2.2. Europe
- 4.2.2.1. Regional Insights
- 4.2.3. Asia Pacific
- 4.2.3.1. Regional Insights
- 4.2.4. Latin America
- 4.2.4.1. Regional Insights
- 4.2.5. Middle East & Africa
- 4.2.5.1. Regional Insights
- 4.2.1. North America
- 4.3. Global Asthma Drugs Market Attractiveness Analysis, By Region
- 5. North America Asthma Drugs Market Analysis and Forecast, 2019-2033
- 5.1. Key Findings
- 5.2. North America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 5.3. North America Asthma Drugs Market Attractiveness Analysis, By Drug Class
- 5.4. North America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 5.5. North America Asthma Drugs Market Attractiveness Analysis, By Product
- 5.6. North America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 5.7. North America Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- 5.8. North America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 5.9. North America Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- 5.10. North America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2019-2033
- 5.11. North America Asthma Drugs Market Attractiveness Analysis, By End-User
- 5.12. North America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 5.13. North America Asthma Drugs Market Attractiveness Analysis, By Country
- 5.13.1. The US
- 5.13.2. Canada
- 6. Europe Asthma Drugs Market Analysis and Forecast, 2019-2033
- 6.1. Key Findings
- 6.2. Europe Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 6.3. Europe Asthma Drugs Market Attractiveness Analysis, By Drug Class
- 6.4. Europe Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 6.5. Europe Asthma Drugs Market Attractiveness Analysis, By Product
- 6.6. Europe Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 6.7. Europe Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- 6.8. Europe Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 6.9. Europe Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- 6.10. Europe Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2019-2033
- 6.11. Europe Asthma Drugs Market Attractiveness Analysis, By End-User
- 6.12. Europe Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 6.13. Europe Asthma Drugs Market Attractiveness Analysis, By Country
- 6.13.1. Germany
- 6.13.2. The UK
- 6.13.3. France
- 6.13.4. Spain
- 6.13.5. Italy
- 6.13.6. Russia
- 6.13.7. Netherland
- 6.13.8. Rest of Europe
- 7. Asia Pacific Asthma Drugs Market Analysis and Forecast, 2019-2033
- 7.1. Key Findings
- 7.2. Asia Pacific Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 7.3. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By Drug Class
- 7.4. Asia Pacific Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 7.5. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By Product
- 7.6. Asia Pacific Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 7.7. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- 7.8. Asia Pacific Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 7.9. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- 7.10. Asia Pacific Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2019-2033
- 7.11. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By End-User
- 7.12. Asia Pacific Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 7.13. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By Country
- 7.13.1. China
- 7.13.2. Japan
- 7.13.3. South Korea
- 7.13.4. India
- 7.13.5. Australia
- 7.13.6. New Zealand
- 7.13.7. Singapore
- 7.13.8. Thailand
- 7.13.9. Vietnam
- 7.13.10. Rest of Asia Pacific
- 8. Latin America Asthma Drugs Market Analysis and Forecast, 2019-2033
- 8.1. Key Findings
- 8.2. Latin America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 8.3. Latin America Asthma Drugs Market Attractiveness Analysis, By Drug Class
- 8.4. Latin America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 8.5. Latin America Asthma Drugs Market Attractiveness Analysis, By Product
- 8.6. Latin America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 8.7. Latin America Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- 8.8. Latin America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 8.9. Latin America Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- 8.10. Latin America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2019-2033
- 8.11. Latin America Asthma Drugs Market Attractiveness Analysis, By End-User
- 8.12. Latin America Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 8.13. Latin America Asthma Drugs Market Attractiveness Analysis, By Country
- 8.13.1. Brazil
- 8.13.2. Mexico
- 8.13.3. Rest of Latin America
- 9. Middle East & Africa Asthma Drugs Market Analysis and Forecast, 2019-2033
- 9.1. Key Findings
- 9.2. Middle East & Africa Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 9.3. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By Drug Class
- 9.4. Middle East & Africa Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 9.5. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By Product
- 9.6. Middle East & Africa Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 9.7. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- 9.8. Middle East & Africa Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 9.9. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- 9.10. Middle East & Africa Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2019-2033
- 9.11. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By End-User
- 9.12. Middle East & Africa Asthma Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 9.13. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By Country
- 9.13.1. South Africa
- 9.13.2. Saudi Arabia
- 9.13.3. UAE
- 9.13.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
- 10.1. Market Competition Scenario Analysis, By Company
- 10.1.1. Key Takeaways
- 10.2. Overview of Major Market Players
- 10.3. Competitor Landscape
- 10.4. Strategic Mapping
- 10.5. Company Life Cycle Analysis
- 10.6. Company Market Share Analysis
- 10.7. Company Profiles
- 10.7.1. Teva Pharmaceutical Industries Ltd.
- 10.7.1.1. Company Details
- 10.7.1.2. Business Overview
- 10.7.1.3. Product Portfolio
- 10.7.1.4. Financial Insights
- 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.1.6. SWOT Analysis
- 10.7.1.7. Geographic Footprint
- 10.7.2. GSK plc
- 10.7.2.1. Company Details
- 10.7.2.2. Business Overview
- 10.7.2.3. Product Portfolio
- 10.7.2.4. Financial Insights
- 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.2.6. SWOT Analysis
- 10.7.2.7. Geographic Footprint
- 10.7.3. Merck & Co., Inc.
- 10.7.3.1. Company Details
- 10.7.3.2. Business Overview
- 10.7.3.3. Product Portfolio
- 10.7.3.4. Financial Insights
- 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.3.6. SWOT Analysis
- 10.7.3.7. Geographic Footprint
- 10.7.4. F. Hoffmann-La Roche Ltd
- 10.7.4.1. Company Details
- 10.7.4.2. Business Overview
- 10.7.4.3. Product Portfolio
- 10.7.4.4. Financial Insights
- 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.4.6. SWOT Analysis
- 10.7.4.7. Geographic Footprint
- 10.7.5. AstraZeneca
- 10.7.5.1. Company Details
- 10.7.5.2. Business Overview
- 10.7.5.3. Product Portfolio
- 10.7.5.4. Financial Insights
- 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.5.6. SWOT Analysis
- 10.7.5.7. Geographic Footprint
- 10.7.6. Boehringer Ingelheim International GmbH
- 10.7.6.1. Company Details
- 10.7.6.2. Business Overview
- 10.7.6.3. Product Portfolio
- 10.7.6.4. Financial Insights
- 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.6.6. SWOT Analysis
- 10.7.6.7. Geographic Footprint
- 10.7.7. Sanofi.
- 10.7.7.1. Company Details
- 10.7.7.2. Business Overview
- 10.7.7.3. Product Portfolio
- 10.7.7.4. Financial Insights
- 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.7.6. SWOT Analysis
- 10.7.7.7. Geographic Footprint
- 10.7.8. Koninklijke Philips N.V.
- 10.7.8.1. Company Details
- 10.7.8.2. Business Overview
- 10.7.8.3. Product Portfolio
- 10.7.8.4. Financial Insights
- 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.8.6. SWOT Analysis
- 10.7.8.7. Geographic Footprint
- 10.7.9. BD
- 10.7.9.1. Company Details
- 10.7.9.2. Business Overview
- 10.7.9.3. Product Portfolio
- 10.7.9.4. Financial Insights
- 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.9.6. SWOT Analysis
- 10.7.9.7. Geographic Footprint
- 10.7.10. Covis Pharma
- 10.7.10.1. Company Details
- 10.7.10.2. Business Overview
- 10.7.10.3. Product Portfolio
- 10.7.10.4. Financial Insights
- 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.10.6. SWOT Analysis
- 10.7.10.7. Geographic Footprint
- 10.7.11. Other Key Players
- 10.7.11.1. Company Details
- 10.7.11.2. Business Overview
- 10.7.11.3. Product Portfolio
- 10.7.11.4. Financial Insights
- 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.11.6. SWOT Analysis
- 10.7.11.7. Geographic Footprint
- 10.7.1. Teva Pharmaceutical Industries Ltd.
- 11. Methodology and Data Source
- 11.1. Methodology/Research Approach
- 11.2. Market Size Estimation
- 11.3. Market Breakdown and Data Triangulation
- 11.4. Data Source
- 11.5. Secondary Sources
- 11.6. Primary Sources
- 11.7. Appendix
- 11.8. Disclaimer
List of Tables
- Table 1. Global Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 2. Global Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 3. Global Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 4. Global Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 5. Global Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 6. Global Asthma Drugs Market Value (US$ Mn), By Region, 2019-2033
- Table 7. North America Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 8. North America Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 9. North America Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 10. North America Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 11. North America Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 12. North America Asthma Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 13. The US Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 14. The US Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 15. The US Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 16. The US Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 17. The US Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 18. Canada Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 19. Canada Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 20. Canada Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 21. Canada Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 22. Canada Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 23. Europe Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 24. Europe Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 25. Europe Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 26. Europe Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 27. Europe Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 28. Europe Asthma Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 29. Germany Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 30. Germany Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 31. Germany Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 32. Germany Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 33. Germany Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 34. The UK Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 35. The UK Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 36. The UK Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 37. The UK Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 38. The UK Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 39. France Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 40. France Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 41. France Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 42. France Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 43. France Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 44. Spain Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 45. Spain Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 46. Spain Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 47. Spain Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 48. Spain Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 49. Italy Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 50. Italy Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 51. Italy Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 52. Italy Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 53. Italy Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 54. Russia Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 55. Russia Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 56. Russia Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 57. Russia Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 58. Russia Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 59. Netherland Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 60. Netherland Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 61. Netherland Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 62. Netherland Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 63. Netherland Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 64. Rest of Europe Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 65. Rest of Europe Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 66. Rest of Europe Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 67. Rest of Europe Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 68. Rest of Europe Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 69. Asia Pacific Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 70. Asia Pacific Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 71. Asia Pacific Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 72. Asia Pacific Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 73. Asia Pacific Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 74. Asia Pacific Asthma Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 75. China Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 76. China Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 77. China Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 78. China Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 79. China Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 80. India Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 81. India Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 82. India Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 83. India Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 84. India Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 85. Japan Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 86. Japan Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 87. Japan Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 88. Japan Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 89. Japan Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 90. South Korea Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 91. South Korea Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 92. South Korea Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 93. South Korea Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 94. South Korea Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 95. Australia Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 96. Australia Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 97. Australia Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 98. Australia Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 99. Australia Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 100. New Zealand Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 101. New Zealand Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 102. New Zealand Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 103. New Zealand Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 104. New Zealand Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 105. Singapore Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 106. Singapore Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 107. Singapore Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 108. Singapore Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 109. Singapore Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 110. Thailand Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 111. Thailand Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 112. Thailand Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 113. Thailand Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 114. Thailand Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 115. Vietnam Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 116. Vietnam Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 117. Vietnam Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 118. Vietnam Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 119. Vietnam Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 120. Rest of Asia Pacific Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 121. Rest of Asia Pacific Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 122. Rest of Asia Pacific Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 123. Rest of Asia Pacific Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 124. Rest of Asia Pacific Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 125. Latin America Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 126. Latin America Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 127. Latin America Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 128. Latin America Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 129. Latin America Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 130. Latin America Asthma Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 131. Brazil Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 132. Brazil Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 133. Brazil Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 134. Brazil Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 135. Brazil Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 136. Mexico Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 137. Mexico Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 138. Mexico Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 139. Mexico Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 140. Mexico Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 141. Rest of Latin America Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 142. Rest of Latin America Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 143. Rest of Latin America Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 144. Rest of Latin America Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 145. Rest of Latin America Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 146. Middle East & Africa Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 147. Middle East & Africa Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 148. Middle East & Africa Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 149. Middle East & Africa Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 150. Middle East & Africa Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 151. Middle East & Africa Asthma Drugs Market Value (US$ Mn), By Country, 2019-2033
- Table 152. South Africa Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 153. South Africa Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 154. South Africa Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 155. South Africa Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 156. South Africa Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 157. Saudi Arabia Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 158. Saudi Arabia Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 159. Saudi Arabia Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 160. Saudi Arabia Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 161. Saudi Arabia Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 162. UAE Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 163. UAE Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 164. UAE Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 165. UAE Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 166. UAE Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
- Table 167. Rest of Middle East & Africa Asthma Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 168. Rest of Middle East & Africa Asthma Drugs Market Value (US$ Mn), By Product, 2019-2033
- Table 169. Rest of Middle East & Africa Asthma Drugs Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 170. Rest of Middle East & Africa Asthma Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 171. Rest of Middle East & Africa Asthma Drugs Market Value (US$ Mn), By End-User, 2019-2033
List of Figures
- Figure 1. Global Asthma Drugs Market Snapshot: Market Value (US$ Mn), 2019-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in the Asthma Drugs Market
- Figure 5. Global Asthma Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 6. Global Asthma Drugs Market Attractiveness Analysis, By Drug Class
- Figure 7. Global Asthma Drugs Market Analysis, By Product, 2019, 2023 and 2033
- Figure 8. Global Asthma Drugs Market Attractiveness Analysis, By Product
- Figure 9. Global Asthma Drugs Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 10. Global Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 11. Global Asthma Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 12. Global Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 13. Global Asthma Drugs Market Analysis, By End-User, 2019, 2023 and 2033
- Figure 14. Global Asthma Drugs Market Attractiveness Analysis, By End-User
- Figure 15. Global Asthma Drugs Market Analysis, By Region, 2019, 2023 and 2033
- Figure 16. Global Asthma Drugs Market Attractiveness Analysis, By Region
- Figure 17. North America Asthma Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 18. North America Asthma Drugs Market Attractiveness Analysis, By Drug Class
- Figure 19. North America Asthma Drugs Market (US$ Mn), by Combination therapies (ICS/LABAs), 2019-2033
- Figure 20. North America Asthma Drugs Market (US$ Mn), by Long-acting beta agonists (LABAs), 2019-2033
- Figure 21. North America Asthma Drugs Market (US$ Mn), by Short-acting beta-agonists (SABAs), 2019-2033
- Figure 22. North America Asthma Drugs Market (US$ Mn), by Inhaled corticosteroids (ICS), 2019-2033
- Figure 23. North America Asthma Drugs Market (US$ Mn), by Oral and intravenous corticosteroids, 2019-2033
- Figure 24. North America Asthma Drugs Market (US$ Mn), by Leukotriene modifiers, 2019-2033
- Figure 25. North America Asthma Drugs Market (US$ Mn), by other drug classes, 2019-2033
- Figure 26. North America Asthma Drugs Market Analysis, By Product, 2019, 2023 and 2033
- Figure 27. North America Asthma Drugs Market Attractiveness Analysis, By Product
- Figure 28. North America Asthma Drugs Market (US$ Mn), by Inhalers, 2019-2033
- Figure 29. North America Asthma Drugs Market (US$ Mn), by Nebulizers, 2019-2033
- Figure 30. North America Asthma Drugs Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 31. North America Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 32. North America Asthma Drugs Market (US$ Mn), by Oral, 2019-2033
- Figure 33. North America Asthma Drugs Market (US$ Mn), by Inhaled, 2019-2033
- Figure 34. North America Asthma Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 35. North America Asthma Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 36. North America Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 37. North America Asthma Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 38. North America Asthma Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 39. North America Asthma Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 40. North America Asthma Drugs Market (US$ Mn), by E-Commerce, 2019-2033
- Figure 41. North America Asthma Drugs Market Analysis, By End-User, 2019, 2023 and 2033
- Figure 42. North America Asthma Drugs Market Attractiveness Analysis, By End-User
- Figure 43. North America Asthma Drugs Market (US$ Mn), by Hospitals & clinics, 2019-2033
- Figure 44. North America Asthma Drugs Market (US$ Mn), by Ambulatory Surgical Centers, 2019-2033
- Figure 45. North America Asthma Drugs Market (US$ Mn), by Homecare settings, 2019-2033
- Figure 46. North America Asthma Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 47. North America Asthma Drugs Market Attractiveness Analysis, By Country
- Figure 48. Europe Asthma Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 49. Europe Asthma Drugs Market Attractiveness Analysis, By Drug Class
- Figure 50. Europe Asthma Drugs Market (US$ Mn), by Combination therapies (ICS/LABAs), 2019-2033
- Figure 51. Europe Asthma Drugs Market (US$ Mn), by Long-acting beta agonists (LABAs), 2019-2033
- Figure 52. Europe Asthma Drugs Market (US$ Mn), by Short-acting beta-agonists (SABAs), 2019-2033
- Figure 53. Europe Asthma Drugs Market (US$ Mn), by Inhaled corticosteroids (ICS), 2019-2033
- Figure 54. Europe Asthma Drugs Market (US$ Mn), by Oral and intravenous corticosteroids, 2019-2033
- Figure 55. Europe Asthma Drugs Market (US$ Mn), by Leukotriene modifiers, 2019-2033
- Figure 56. Europe Asthma Drugs Market (US$ Mn), by other drug classes, 2019-2033
- Figure 57. Europe Asthma Drugs Market Analysis, By Product, 2019, 2023 and 2033
- Figure 58. Europe Asthma Drugs Market Attractiveness Analysis, By Product
- Figure 59. Europe Asthma Drugs Market (US$ Mn), by Inhalers, 2019-2033
- Figure 60. Europe Asthma Drugs Market (US$ Mn), by Nebulizers, 2019-2033
- Figure 61. Europe Asthma Drugs Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 62. Europe Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 63. Europe Asthma Drugs Market (US$ Mn), by Oral, 2019-2033
- Figure 64. Europe Asthma Drugs Market (US$ Mn), by Inhaled, 2019-2033
- Figure 65. Europe Asthma Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 66. Europe Asthma Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 67. Europe Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 68. Europe Asthma Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 69. Europe Asthma Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 70. Europe Asthma Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 71. Europe Asthma Drugs Market (US$ Mn), by E-Commerce, 2019-2033
- Figure 72. Europe Asthma Drugs Market Analysis, By End-User, 2019, 2023 and 2033
- Figure 73. Europe Asthma Drugs Market Attractiveness Analysis, By End-User
- Figure 74. Europe Asthma Drugs Market (US$ Mn), by Hospitals & clinics, 2019-2033
- Figure 75. Europe Asthma Drugs Market (US$ Mn), by Ambulatory Surgical Centers, 2019-2033
- Figure 76. Europe Asthma Drugs Market (US$ Mn), by Homecare settings, 2019-2033
- Figure 77. Europe Asthma Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 78. Europe Asthma Drugs Market Attractiveness Analysis, By Country
- Figure 79. Asia Pacific Asthma Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 80. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By Drug Class
- Figure 81. Asia Pacific Asthma Drugs Market (US$ Mn), by Combination therapies (ICS/LABAs), 2019-2033
- Figure 82. Asia Pacific Asthma Drugs Market (US$ Mn), by Long-acting beta agonists (LABAs), 2019-2033
- Figure 83. Asia Pacific Asthma Drugs Market (US$ Mn), by Short-acting beta-agonists (SABAs), 2019-2033
- Figure 84. Asia Pacific Asthma Drugs Market (US$ Mn), by Inhaled corticosteroids (ICS), 2019-2033
- Figure 85. Asia Pacific Asthma Drugs Market (US$ Mn), by Oral and intravenous corticosteroids, 2019-2033
- Figure 86. Asia Pacific Asthma Drugs Market (US$ Mn), by Leukotriene modifiers, 2019-2033
- Figure 87. Asia Pacific Asthma Drugs Market (US$ Mn), by other drug classes, 2019-2033
- Figure 88. Asia Pacific Asthma Drugs Market Analysis, By Product, 2019, 2023 and 2033
- Figure 89. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By Product
- Figure 90. Asia Pacific Asthma Drugs Market (US$ Mn), by Inhalers, 2019-2033
- Figure 91. Asia Pacific Asthma Drugs Market (US$ Mn), by Nebulizers, 2019-2033
- Figure 92. Asia Pacific Asthma Drugs Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 93. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 94. Asia Pacific Asthma Drugs Market (US$ Mn), by Oral, 2019-2033
- Figure 95. Asia Pacific Asthma Drugs Market (US$ Mn), by Inhaled, 2019-2033
- Figure 96. Asia Pacific Asthma Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 97. Asia Pacific Asthma Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 98. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 99. Asia Pacific Asthma Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 100. Asia Pacific Asthma Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 101. Asia Pacific Asthma Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 102. Asia Pacific Asthma Drugs Market (US$ Mn), by E-Commerce, 2019-2033
- Figure 103. Asia Pacific Asthma Drugs Market Analysis, By End-User, 2019, 2023 and 2033
- Figure 104. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By End-User
- Figure 105. Asia Pacific Asthma Drugs Market (US$ Mn), by Hospitals & clinics, 2019-2033
- Figure 106. Asia Pacific Asthma Drugs Market (US$ Mn), by Ambulatory Surgical Centers, 2019-2033
- Figure 107. Asia Pacific Asthma Drugs Market (US$ Mn), by Homecare settings, 2019-2033
- Figure 108. Asia Pacific Asthma Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 109. Asia Pacific Asthma Drugs Market Attractiveness Analysis, By Country
- Figure 110. Latin America Asthma Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 111. Latin America Asthma Drugs Market Attractiveness Analysis, By Drug Class
- Figure 112. Latin America Asthma Drugs Market (US$ Mn), by Combination therapies (ICS/LABAs), 2019-2033
- Figure 113. Latin America Asthma Drugs Market (US$ Mn), by Long-acting beta agonists (LABAs), 2019-2033
- Figure 114. Latin America Asthma Drugs Market (US$ Mn), by Short-acting beta-agonists (SABAs), 2019-2033
- Figure 115. Latin America Asthma Drugs Market (US$ Mn), by Inhaled corticosteroids (ICS), 2019-2033
- Figure 116. Latin America Asthma Drugs Market (US$ Mn), by Oral and intravenous corticosteroids, 2019-2033
- Figure 117. Latin America Asthma Drugs Market (US$ Mn), by Leukotriene modifiers, 2019-2033
- Figure 118. Latin America Asthma Drugs Market (US$ Mn), by other drug classes, 2019-2033
- Figure 119. Latin America Asthma Drugs Market Analysis, By Product, 2019, 2023 and 2033
- Figure 120. Latin America Asthma Drugs Market Attractiveness Analysis, By Product
- Figure 121. Latin America Asthma Drugs Market (US$ Mn), by Inhalers, 2019-2033
- Figure 122. Latin America Asthma Drugs Market (US$ Mn), by Nebulizers, 2019-2033
- Figure 123. Latin America Asthma Drugs Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 124. Latin America Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 125. Latin America Asthma Drugs Market (US$ Mn), by Oral, 2019-2033
- Figure 126. Latin America Asthma Drugs Market (US$ Mn), by Inhaled, 2019-2033
- Figure 127. Latin America Asthma Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 128. Latin America Asthma Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 129. Latin America Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 130. Latin America Asthma Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 131. Latin America Asthma Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 132. Latin America Asthma Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 133. Latin America Asthma Drugs Market (US$ Mn), by E-Commerce, 2019-2033
- Figure 134. Latin America Asthma Drugs Market Analysis, By End-User, 2019, 2023 and 2033
- Figure 135. Latin America Asthma Drugs Market Attractiveness Analysis, By End-User
- Figure 136. Latin America Asthma Drugs Market (US$ Mn), by Hospitals & clinics, 2019-2033
- Figure 137. Latin America Asthma Drugs Market (US$ Mn), by Ambulatory Surgical Centers, 2019-2033
- Figure 138. Latin America Asthma Drugs Market (US$ Mn), by Homecare settings, 2019-2033
- Figure 139. Latin America Asthma Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 140. Latin America Asthma Drugs Market Attractiveness Analysis, By Country
- Figure 141. Middle East & Africa Asthma Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 142. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By Drug Class
- Figure 143. Middle East & Africa Asthma Drugs Market (US$ Mn), by Combination therapies (ICS/LABAs), 2019-2033
- Figure 144. Middle East & Africa Asthma Drugs Market (US$ Mn), by Long-acting beta agonists (LABAs), 2019-2033
- Figure 145. Middle East & Africa Asthma Drugs Market (US$ Mn), by Short-acting beta-agonists (SABAs), 2019-2033
- Figure 146. Middle East & Africa Asthma Drugs Market (US$ Mn), by Inhaled corticosteroids (ICS), 2019-2033
- Figure 147. Middle East & Africa Asthma Drugs Market (US$ Mn), by Oral and intravenous corticosteroids, 2019-2033
- Figure 148. Middle East & Africa Asthma Drugs Market (US$ Mn), by Leukotriene modifiers, 2019-2033
- Figure 149. Middle East & Africa Asthma Drugs Market (US$ Mn), by other drug classes, 2019-2033
- Figure 150. Middle East & Africa Asthma Drugs Market Analysis, By Product, 2019, 2023 and 2033
- Figure 151. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By Product
- Figure 152. Middle East & Africa Asthma Drugs Market (US$ Mn), by Inhalers, 2019-2033
- Figure 153. Middle East & Africa Asthma Drugs Market (US$ Mn), by Nebulizers, 2019-2033
- Figure 154. Middle East & Africa Asthma Drugs Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 155. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 156. Middle East & Africa Asthma Drugs Market (US$ Mn), by Oral, 2019-2033
- Figure 157. Middle East & Africa Asthma Drugs Market (US$ Mn), by Inhaled, 2019-2033
- Figure 158. Middle East & Africa Asthma Drugs Market (US$ Mn), by Others, 2019-2033
- Figure 159. Middle East & Africa Asthma Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 160. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 161. Middle East & Africa Asthma Drugs Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 162. Middle East & Africa Asthma Drugs Market (US$ Mn), by Hospital Pharmacies, 2019-2033
- Figure 163. Middle East & Africa Asthma Drugs Market (US$ Mn), by Retail Pharmacies, 2019-2033
- Figure 164. Middle East & Africa Asthma Drugs Market (US$ Mn), by E-Commerce, 2019-2033
- Figure 165. Middle East & Africa Asthma Drugs Market Analysis, By End-User, 2019, 2023 and 2033
- Figure 166. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By End-User
- Figure 167. Middle East & Africa Asthma Drugs Market (US$ Mn), by Hospitals & clinics, 2019-2033
- Figure 168. Middle East & Africa Asthma Drugs Market (US$ Mn), by Ambulatory Surgical Centers, 2019-2033
- Figure 169. Middle East & Africa Asthma Drugs Market (US$ Mn), by Homecare settings, 2019-2033
- Figure 170. Middle East & Africa Asthma Drugs Market Analysis, By Country, 2019, 2023 and 2033
- Figure 171. Middle East & Africa Asthma Drugs Market Attractiveness Analysis, By Country
- 1. Executive Summary
- Teva Pharmaceutical Industries Ltd. Company Profile
- GSK plc
- Merck & Co., Inc.
- F. Hoffmann-La Roche Ltd
- AstraZeneca Plc Company Profile
- Boehringer Ingelheim International GmbH
- Sanofi.
- Koninklijke Philips N.V.
- Becton, Dickinson and Company Profile
- Covis Pharma
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible Single User $6,000 $3,999 USD / per unit save 24% | Multi User $8,000 $5,999 USD / per unit save 28% | Corporate User $10,000 $6,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |